Novartis | NVS - SCHULD

Aktienkurs
151.99
Täglich Wechseln
2.19 1.46%
Monatlich
1.50%
Jährlich
37.42%
Q2 Prognose
150.72




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bausch Health Companies USD 21.04B 696M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.36M 247K 2025-09
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
J&J USD 47.93B 2.14B 2025-12
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Novartis USD 32.02B 615M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Zoetis USD 7.27B 482M 2025-09